StockIQ.techIntuitive Surgical Inc. (ISRG) Stock Analysis
Free AI-powered analysis and research for Intuitive Surgical Inc. stock
Sector: Healthcare
ISRG snapshot
Data as of 3 Nov 2026 close. Updated daily.
Intuitive Surgical Inc. scores 69/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 40% of its 52-week range, down 19.3% over the past year. Latest reported figures show a profit margin of 25.5%, return on equity of 17.9% and revenue growth of +21.7%.
What is driving the score
- RSI Neutral: +5
- Strong Uptrend: +10
- MACD Bearish: -8
- High P/E (52.2): -10
- Strong Revenue Growth (21.7%): +8
- Excellent Profit Margin (25.5%): +10
- Strong Liquidity (3.33 Current Ratio): +8
- Strong ROE (17.9%): +5
- High P/B (9.37): -5
- Above MA200: +4
- Underperforming (-19.3% over 1 year): -5
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ISRG report
Intuitive Surgical Inc. (ISRG) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ISRG Now →📰 Latest Update
Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
Sun, November 1, 2026 at 8:35 PM UTC 3 min read
Intuitive Surgical's stock fell despite a 22% revenue increase, as investors are concerned about rising competition from Medtronic and Johnson & Johnson in the surgical robotics market. However, the article highlights that sales of the da Vinci surgical robot only account for about 25% of the company's revenue, with instruments, accessories, and services driving the majority. Despite competition, Intuitive Surgical's strong foundation of recurring income and growing demand for robotic surgery suggest potential for continued growth.